ArticleAnnals of medicine and surgery (2012)2026

Jideytro (zidesamtinib) for previously treated ros1-positive non-small cell lung cancer: a new era in post-tki therapy.

Syeda Fadak Zahra Hujjat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.